Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Anushka Bakshi

- PMLiVE

No deal for Stada as private equity takeover bid collapses

65.52% of investors supported the takeover, just shy of the 67.5% needed to close the deal

Digital disruption

How pharma is keeping up with the pace of change

- PMLiVE

ThromoboGenics appoints Thomas Clay as chairman of the board

He moves from his previous position as non-executive director

- PMLiVE

Dr Desiree Luthman joins Verona Pharma

She takes up its vice president position

- PMLiVE

Europe delays EMA relocation decision

Will resolve the issue in November, one month later than expected

- PMLiVE

Shoring up the framework

European regulators add a measure of clarity to pharma’s uncertainty around Brexit

- PMLiVE

Samsung Bioepis wins CHMP nod for second Humira biosimilar

In addition to Imraldi the regulatory advisors also backed new medicines from AbbVie and Gilead

- PMLiVE

Merck gets CHMP backing for long-delayed oral MS drug

Cladribine, which will be branded as Mavenclad, was originally rejected by the committee in 2010

PEGASUS SHOWREEL 2017

Inizio

Sermo reaches 150,000 members after global expansion drive

Online physician community now has doors open in more than 150 new countries

- PMLiVE

Healthcare communications to journalists “on life support”

Only 2% of journalists surveyed find information provided by pharma 'trustworthy'

Good news, bad news

The world will spend more on healthcare but will spend it differently

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links